Fuda Cancer Hospital - Malaysia

23/04/2026

[Patient Story] [Malaysia – Lung Cancer – Arterial Infusion Chemotherapy]
Rare Lung Cancer Malaysian Given “Only 3 Months to Live” — Fuda’s

Comprehensive Treatment Brings Her New Hope
“Rare,” “large tumor,” “rapid progression,” “fast ,” “highly metastatic”… these recurrence are the words Nuru (pseudonym) uses to describe her condition.
In her early forties, Nuru is from Malaysia. In January 2025, she sought medical attention at a local hospital due to persistent cough and fever. An X-ray revealed a mass in her right lung, and a biopsy confirmed poorly differentiated non-small cell carcinoma. She underwent a right upper lobectomy, but the postoperative pathology revealed a more troubling truth: poorly differentiated carcinoma with pleomorphic and sarcomatoid components.

This was no ordinary lung cancer.
Pulmonary sarcomatoid carcinoma (PSC) is an extremely rare subtype of non-small cell lung cancer, accounting for only 0.1%–0.5% of all lung malignancies. It typically presents with larger tumors, often showing hemorrhage and necrosis on section, with a fish-flesh appearance. It progresses rapidly and is highly prone to recurrence and metastasis — Nuru’s subsequent experience would tragically mirror this description.
After surgery, her PD-L1 test showed a TPS of 35%, and she underwent five cycles of immunotherapy. However, in April 2025, a PET-CT scan revealed tumor recurrence, with the largest lesion measuring 7 cm and multiple lymph node metastases. Genetic testing also indicated a SMARCA4-deficient mutation — found in approximately 5–10% of non-small cell lung cancers and typically associated with poor prognosis.
This made Nuru realize that cancer was not so easily defeated.
Still, she did not give up. She tried radiotherapy and immunotherapy, but the tumor grew aggressively, reaching a maximum diameter of 15.7 cm, invading the ribs, and causing superior vena cava syndrome. Local doctors were left with no options and concluded she had “only three months to live.”
Even more heartbreaking, due to the severity of her condition, she was refused admission by multiple hospitals. Even when admitted, she was only offered palliative care to relieve symptoms, rather than active anti-tumor treatment.
“Is this really the end?”
She sought medical help everywhere. She learned that other patients had been treated at Fuda Cancer Hospital in Guangzhou, China, and some doctors also recommended she try Fuda’s approach. After multiple online consultations, Nuru got in touch with the medical team at Fuda. Holding onto a glimmer of hope, she decided to come to China.
“Extremely thin, almost skin and bones, unable to walk…” — this was the first impression of Nuru by the medical staff at Fuda. At that time, she weighed just over 30 kg, and the tumor in her lung had grown to 17.6 cm.
Nuru was already in the advanced stage of lung cancer with multiple metastases throughout her body. Surgery was no longer an option, and treatment focused primarily on palliative care. After multidisciplinary consultation and comprehensive evaluation, the Fuda First Medical Department formulated a personalized treatment plan:
Arterial infusion chemotherapy: Delivering drugs directly into the arteries supplying the tumor, achieving a much higher local concentration than systemic intravenous chemotherapy. Nuru remarked, “In our country, interventional therapy is only used for the liver, but at Fuda, it’s applied in many areas.”
Combination immunotherapy + anti-angiogenic therapy: Inhibiting the formation of new blood vessels in tumors, improving the tumor microenvironment, and enhancing immune response.
After several treatment cycles, Nuru’s symptoms — cough, shortness of breath, and persistent fever — improved significantly. The tumor in her right lung shrank compared to before, and the treatment response was evaluated as SD (stable disease). Her weight increased from just over 30 kg to 48 kg. From being bedridden, she now feels that returning to jogging is within reach. “After returning home, other doctors were surprised by my recovery.”
Nuru admitted that she had consulted other overseas medical institutions, but many claimed to offer “miracle treatments” without providing concrete treatment plans. She pointed out two key reasons why choosing Fuda was the right decision:
First, Fuda did not refuse her despite her critical condition, giving her hope to live;
Second, since her diagnosis, the first positive treatment results she heard came from Fuda.
What touched her most was the consistent warmth of the medical staff: “They never say discouraging words,” always greet her with smiles, and clearly explain and adjust every step of treatment, keeping her informed about her condition at all times.

Today, Nuru is still undergoing systemic anti-tumor therapy. However, she is no longer fixated on “completely eliminating cancer,” but has learned to live with it. From being told she had only three months to live to regaining hope of jogging again, her journey has been incredibly difficult — but she is no longer alone.
We believe she will continue to improve.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

23/04/2026

【患者故事】【马来西亚-肝癌-介入】
>>> 四期肝癌拒绝手术，介入化疗助他安眠> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們：
☎️電話: +60 19 996 4656
🌟Whatsapp: 60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

23/04/2026

【Paitent’s Story】【Malaysia - Liver Cancer - Interventional Chemotherapy】
>>>Stage IV Liver Cancer: No Surgery, Better Sleep After Interventional Therapy> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

23/04/2026

【Patient’s Story】【Antigua – Oropharyngeal Cancer – Arterial Infusion Embolization】
>>>Oropharyngeal Cancer Patient Refuses Surgery: Rapid Improvement After treated in Fuda> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

15/04/2026

【Paitent’s Story】【Antigua – Oropharyngeal Cancer – Arterial Infusion Embolization】
>>>Oropharyngeal Cancer Patient Refuses Surgery: Rapid Improvement After treated in Fuda> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

15/04/2026

【患者故事】【安提瓜-口咽癌-动脉灌注栓塞】
>>> 口咽癌患者拒绝手术，跨国求医改善明显> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們：
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

14/04/2026

【患者故事】【俄罗斯-胰腺癌-介入】
胰头癌多处转移的俄罗斯老教师，为何给医生献上“吻手礼”？
一场胆囊结石的术前检查，却意外触发了命运的转折——胰头占位。对于祖尔菲娅（化名）来说，所有痛苦的序幕，都从这场“意外”拉开。
意外发现的“胰腺癌”

72岁的祖尔菲娅来自俄罗斯，是一名大学老师。去年9月，她因右上腹部隐痛不适到医院就诊，超声提示为胆囊结石。治疗前，她做了一次腹部增强CT，这次的结果，可不止结石那么简单——胰头上有个21×19mm的占位性病变，肝内出现多发病灶，腹膜后淋巴结也出现肿大。
这突如其来的消息，彻底打乱了她的生活。得知病情后，祖尔菲娅花了一个多月的时间在当地接受了各项检查，确诊为胰头癌全身多处转移（肝脏、骨骼等）。她的病情发展得很快，短短一个月内就无法行走，右腿失去力量，胸部、背部、腹部也痛得不行，背部皮下也出现肿物。
当地医院建议化疗，但漫长的等待让病情无法再拖。一次偶然的机会，家人从社交媒体上看到有俄罗斯患者在中国广州复大肿瘤医院接受治疗的经历，抱着最后一丝希望，他们联系上了医院驻莫斯科办事处。经过详细咨询，祖尔菲娅和家人决定到广州寻求治疗。

转机，从这开始

祖尔菲娅抵达广州复大肿瘤医院时，身体状况很差，无法独立行走，甚至担心医院会因此放弃她。检查结果显示，她的病情比预想的更复杂：胰头的肿瘤已经增大至58×54×74mm，向前侵犯胃窦后壁，向内侵犯十二指肠肠壁，且肝脏、淋巴结及骨骼多处转移。
面对这样棘手的情况，复大医疗四科的团队没有退缩。他们为祖尔菲娅制定了谨慎、分阶段的治疗计划。
医疗团队先为其肩背部肿物做了一个活检术，明确性质，结果提示为转移性腺癌，考虑为胰腺癌转移。由于祖尔菲娅入院后出现不稳定性心绞痛，身体条件暂时不适合介入灌注动脉化疗，医疗团队调整了方案，先给予营养心肌、扩管治疗等对症治疗，后进行口服化疗药物，同时联合免疫与靶向治疗，力求在控制病情的同时，尽量减少对身体额外的负担。
三个疗程后，令人欣慰的变化慢慢出现了。从最初起不了床、需要人搀扶，祖尔菲娅渐渐能自己下地行走。疼痛得到了有效缓解，体重也开始回升。让她特别意外的是，治疗期间，她的头发没有像想象中那样掉光，反而还长出来了。这些细微的变化，给了她巨大的信心。
随着身体状况的稳定，医疗团队又为她施行了介入治疗。这种治疗方式通过导管将化疗药物直接注入肿瘤供血动脉，在控制肿瘤的同时，尽可能减少对全身的影响。今年3月的影像复查显示，她体内的多处淋巴结较前缩小，各项化验结果也无明显异常。

她吻了医生的手，那是“不放弃”的感谢

住院的日子里，祖尔菲娅从最初的担忧，慢慢变得安心。她在这，感受到了中国科技的发展，感受到了广州的热情好客，感受到了复大优质的医疗服务。她感慨，这里的院区虽然不大，但“五脏俱全”，医护人员响应快，技术让她感到信任。
在一次查房时，她紧紧握住主管医生张营的手，轻轻行了一个“吻手礼”。这个“礼”感谢的不仅是医生的技术，更是那份没有因为病情复杂而放弃她的坚持，也是医患互相理解互相支持，共同战胜疾病的决心。

祖尔菲娅不知道自己未来会是如何，但取得这样的结果，她非常满意。如今，我们在祖尔菲娅身上看到了从容，看到了和蔼，也看到了微笑，她有信心，自己会越来越好。

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們：
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

14/04/2026

[Patient Story] [Russia – Pancreatic Cancer – Interventional Therapy]
Why did Russian elderly with metastatic pancreatic cancer offer a “hand-kiss” to doctor?
A preoperative checkup for gallstones unexpectedly triggered a turning point in her life— a mass in the pancreatic head. For Zulfiia (pseudonym), all the suffering began with this “accident.”
An Unexpected Diagnosis of Pancreatic Cancer
Zulfiia, 72, is a university teacher from Russia. In September last year, she visited a hospital due to dull pain and discomfort in the upper right abdomen. An ultrasound suggested gallstones. Before treatment, she underwent an enhanced abdominal CT scan. The results revealed more than just stones—a 21×19 mm mass in the pancreatic head, multiple lesions in the liver, and enlarged retroperitoneal lymph nodes.
This sudden news completely disrupted her life. After learning about her condition, Zulfiia spent over a month undergoing various examinations locally and was diagnosed with pancreatic head cancer with multiple systemic metastases (liver, bones, etc.). Her condition progressed rapidly. Within just one month, she lost the ability to walk, her right leg became weak, and she suffered severe pain in her chest, back, and abdomen. A subcutaneous mass also appeared on her back.
Local doctors recommended chemotherapy, but the long waiting time meant her condition could not afford further delay. By chance, her family came across stories on social media about Russian patients receiving treatment at Guangzhou Fuda Cancer Hospital in China. Holding onto a final hope, they contacted the hospital’s Moscow office. After detailed consultations, Zulfiia and her family decided to travel to Guangzhou for treatment.
A Turning Point Begins Here
When Zulfiia arrived at Guangzhou Fuda Cancer Hospital, her condition was poor. She could not walk independently and even worried that the hospital might refuse to treat her. Examinations showed her condition was more complex than expected: the pancreatic tumor had grown to 58×54×74 mm, invading the posterior wall of the gastric antrum and the duodenal wall, with multiple metastases in the liver, lymph nodes, and bones.
Faced with such a challenging situation, the medical team from the Fourth Department at Fuda did not retreat. They developed a cautious, step-by-step treatment plan.
The team first performed a biopsy of the mass on her shoulder and back to determine its nature. The result indicated metastatic adenocarcinoma, likely originating from pancreatic cancer. After admission, Zulfiia developed unstable angina, making her temporarily unsuitable for interventional arterial infusion chemotherapy. The team adjusted the treatment plan, starting with supportive therapies such as myocardial nutrition and vasodilation, followed by oral chemotherapy combined with immunotherapy and targeted therapy. The goal was to control the disease while minimizing additional burden on her body.
After three treatment cycles, encouraging changes gradually appeared. From being bedridden and needing assistance, Zulfiia was eventually able to walk on her own. Her pain was effectively relieved, and her weight began to increase. What surprised her most was that, during treatment, her hair did not fall out as expected—instead, it even started to grow. These subtle improvements greatly boosted her confidence.
As her condition stabilized, the medical team proceeded with interventional therapy. This treatment delivers chemotherapy drugs directly into the arteries supplying the tumor via a catheter, helping control the tumor while minimizing systemic side effects. Imaging follow-up in March this year showed that multiple lymph nodes had shrunk compared to before, and her laboratory results showed no significant abnormalities.
A Hand-Kiss of Gratitude for “Not Giving Up”
During her hospitalization, Zulfiia gradually moved from anxiety to peace of mind. She experienced China’s medical advancements, Guangzhou’s hospitality, and the high-quality care at Fuda. She remarked that although the hospital is not large, it is fully equipped, with responsive staff and trustworthy technology.
During one ward round, she tightly held the hand of her attending physician, Dr. Zhang Ying, and gently performed a “hand-kiss.” This gesture was not only a token of gratitude for the doctor’s skills, but also for their persistence in not giving up on her despite the complexity of her condition. It symbolized the mutual understanding and support between doctor and patient, and their shared determination to fight the disease together.

Zulfiia does not know what the future holds, but she is very satisfied with the results achieved so far. Today, we see in her a sense of calm, kindness, and a smile. She believes that she will continue to get better.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

14/04/2026

【患者故事】【香港-舌癌-介入】
舌癌转移脖子肿瘤破溃，香港女子内地求医
“再这样化疗下去，没病也要被医出病来……”
说这话的是周姐的弟弟。他陪着患癌的姐姐四处求医，眼看着她在化疗后，头发掉光，被折磨得不成人样。他心疼，也急了。
“不能再这样下去了。

舌癌三期，化疗把人“治垮了”
周姐来自中国香港。2024年年底，周姐摸到自己左侧脖子有一凸起肿块，头疼、吃不下饭、……这些症状接踵而至。
等到医院确诊，已经是舌癌三期，伴有淋巴结转移，还越长越快。
那一刻，周姐和弟弟都懵了。
他们没有癌症的经验，也不想要这种经验。他们听从当地医生的建议，先做化疗、放疗。可谁能想到，一次化疗下来，姐姐就像换了个人。
头发掉光，人也虚弱。后来她又试了别的药，像赌博一样，盼着能碰上一点希望。可老天没站在她这边——药没见效，身体却被拖垮了。

眼光放远，转机出现
弟弟看着她，心里像被什么东西揪着。他开始求神拜佛，四处打听，试图为姐姐缓解痛苦。可一圈下来，他发现，在香港，传统治疗似乎走到底了。
最后，一位做自然疗法的好朋友对他说：“你别只盯着香港，眼光放远一点，外面也许有别的办法。”朋友给他推荐了一家专治肿瘤的医院——广州复大肿瘤医院。在查阅多方资料，并与复大医护人员联系后，他决定试一试。
2025年4月，他带着姐姐，来到广州，入住复大医疗三科。
一进医院，弟弟就留意到一个细节：这里的病人，来自很多国家和地区。“这么多人愿意跑这么远来治，肯定有它的道理。”他想。

同样化疗，却天差地别
入院时，周姐脖子上两侧都有肿大的淋巴结，左边那个尤其明显，差不多有5厘米大，表面已经破溃，渗出黄色的液体。整个人憔悴得让人心疼。医院很快组织了多学科会诊，专家团队商量后，决定给她做介入化疗。

“副反应简直是天差地别。”这是周家姐弟对介入治疗的第一印象。即使在来之前已经了解过介入治疗——不用全身给药，而是把一根很细的导管，精准送到肿瘤的供血动脉，局部给药，“毒死”肿瘤，再堵住血管，“饿死”它。
不过，肿瘤缩小的速度还是不够理想。几次介入下来，配合靶向和免疫药物，肿瘤没再长大，但也缩得不太明显。为了进一步减轻肿瘤负荷，医生建议做碘粒子植入术——把放射性粒子精准植入肿瘤内部，从里面“定点清除”癌细胞。术后再配合靶向药。
一个月后复查，肿瘤明显缩小，达到了“PR”疗效——也就是部分缓解。之后复查的频率，从一个月一次，拉长到两个月一次，结果一次比一次好。

“我不再当她是病人了”
回想这一年，弟弟说，真的太累了。
不是身体上的累，是心里的那种累。看着姐姐难受，自己也跟着难受。让他感动的是，复大的医护人员，很懂他们。
“他们知道癌症病人和家属的心情，不光治病，也治心。”弟弟说，“生病已经很辛苦了，如果还要被冷眼相对，那真的太难受了。”
如今，周姐的生活基本恢复正常。除了还在吃靶向药，偶尔有些轻微副作用，她已经可以像普通人一样过日子。
弟弟笑着说：“我现在不把她当病人了，她好了八九成了。”

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們：
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

14/04/2026

[Patient Story] [Hong Kong – Tongue Cancer – Interventional Therapy]
Neck Tumor Ulceration After Tongue Cancer Metastasis: Hong Kong Woman Seeks Treatment in Mainland China
“If this chemotherapy continues, it will make a healthy person sick…”
These were the words of Ms. Zhou’s younger brother. He had been accompanying his sister in her fight against cancer, traveling from place to place in search of treatment. After chemotherapy, he watched her lose all her hair and become almost unrecognizable from the suffering. He was heartbroken—and desperate.
“We can’t go on like this.”

Stage III Tongue Cancer: Chemotherapy Took a Toll
Ms. Zhou is from Hong Kong, China. At the end of 2024, she noticed a lump on the left side of her neck. Soon after, symptoms such as headaches and loss of appetite followed one after another.
By the time she was diagnosed at the hospital, it was already stage III tongue cancer, with lymph node metastasis, and the tumor was growing rapidly.
At that moment, both Ms. Zhou and her brother were overwhelmed.
They had no experience with cancer—and certainly never wanted to have any. Following the advice of local doctors, she began chemotherapy and radiotherapy. But after just one round of chemotherapy, it was as if she had become a different person.
Her hair fell out, and her body became extremely weak. Later, she tried other medications, like gambling on a slim chance of hope. But luck was not on her side—the drugs showed no effect, while her body continued to deteriorate.

Looking Beyond: A Turning Point
Watching his sister suffer felt like a constant weight on her brother’s heart. He sought help everywhere—praying, asking around—hoping to ease her pain.
But after exhausting options in Hong Kong, he realized that conventional treatments seemed to have reached their limit.
Finally, a friend who practiced natural therapy told him:
“Don’t just focus on Hong Kong. Look further—there may be other options outside.”
The friend recommended a specialized cancer hospital: Fuda Cancer Hospital in Guangzhou. After researching extensively and contacting the hospital staff, he decided to give it a try.
In April 2025, he brought his sister to Guangzhou, where she was admitted to the Third Medical Department of Fuda.
Upon arrival, he noticed something striking—patients here came from many different countries and regions.
“So many people are willing to travel this far for treatment—there must be a reason,” he thought.

The Same Chemotherapy—A World of Difference
At admission, Ms. Zhou had enlarged lymph nodes on both sides of her neck. The one on the left was particularly prominent—about 5 cm in size—with ulceration on the surface and yellow fluid discharge. She looked extremely frail.

The hospital quickly organized a multidisciplinary team (MDT) consultation. After discussion, the experts decided to proceed with interventional chemotherapy.
“The side effects were completely different,” the siblings said, describing their first impression.
Before coming, they had already learned that interventional therapy does not rely on systemic drug delivery. Instead, a very thin catheter is precisely guided into the artery supplying the tumor, allowing chemotherapy drugs to be delivered directly to the tumor—“poisoning” it—while simultaneously blocking its blood supply to “starve” it.
However, the tumor did not shrink as quickly as expected. After several sessions of interventional therapy combined with targeted therapy and immunotherapy, the tumor stopped growing, but the reduction was not very obvious.
To further reduce the tumor burden, doctors recommended iodine-125 seed implantation—a procedure that places radioactive seeds directly inside the tumor to eliminate cancer cells from within. This was followed by targeted therapy.
One month later, follow-up examination showed significant tumor shrinkage, achieving PR (Partial Response).
Subsequent follow-ups were gradually extended from once a month to once every two months—and each time, the results kept improving.

“I No Longer See Her as a Patient”
Looking back on the past year, her brother said it had been exhausting.
Not physically—but emotionally. Watching his sister suffer made him suffer as well.
What touched him most was the understanding shown by the medical staff at Fuda.
“They truly understand the feelings of cancer patients and their families. They don’t just treat the disease—they care for the heart as well,” he said.
“Being sick is already hard enough. If you’re treated coldly on top of that, it’s unbearable.”
Today, Ms. Zhou’s life has largely returned to normal. Apart from continuing targeted therapy and experiencing occasional mild side effects, she is able to live much like a healthy person.
Her brother said with a smile:
“I no longer see her as a patient—she’s 80–90% recovered.”

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

11/04/2026